Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2

<i><b>Background/Objectives</b></i>: Our previous study demonstrated that while the third SARS-CoV-2 booster effectively enhanced immunity against the Delta subvariant, its protection declined over time. This study aimed to evaluate and compare the humoral and cellular immune responses, as well as r...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Auchara Tangsathapornpong, Sira Nanthapisal, Waraphon Fukpho, Pornumpa Bunjoungmanee, Yamonbhorn Neamkul, Kanassanan Pontan, Arthit Boonyarangkul, Supattra Wanpen, Kanokporn Thongphubeth, Phuntila Tharabenjasin, Peera Jaru-Ampornpan
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2026-04-01
سلاسل:	Vaccines
الموضوعات:	SARS-CoV-2 vaccine CoronaVac AZD1222 BNT162b2 mRNA-1273 booster dose
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-393X/14/4/348
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!